Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | roundabout 2 | 0.0014 | 0.0137 | 0.0137 |
Schistosoma mansoni | vesicular amine transporter | 0.0011 | 0.0099 | 0.0466 |
Schistosoma mansoni | tyrosine kinase | 0.0098 | 0.1241 | 0.5855 |
Loa Loa (eye worm) | TK/KIN16 protein kinase | 0.0013 | 0.0112 | 0.053 |
Echinococcus multilocularis | basement membrane specific heparan sulfate | 0.0011 | 0.0099 | 0.0099 |
Schistosoma mansoni | cell adhesion molecule | 0.0011 | 0.0099 | 0.0466 |
Echinococcus multilocularis | fibroblast growth factor receptor 4 | 0.0098 | 0.1241 | 0.1241 |
Schistosoma mansoni | defective proboscis extension response (dpr)-related | 0.0011 | 0.0099 | 0.0466 |
Loa Loa (eye worm) | hypothetical protein | 0.0014 | 0.0137 | 0.0647 |
Echinococcus granulosus | twitchin | 0.0015 | 0.0143 | 0.0143 |
Brugia malayi | Protein kinase domain containing protein | 0.0165 | 0.2119 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0165 | 0.2119 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.0099 | 0.0466 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.0099 | 0.0466 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.0099 | 0.0466 |
Echinococcus granulosus | defective proboscis extension response | 0.0011 | 0.0099 | 0.0099 |
Echinococcus multilocularis | roundabout 2 | 0.0014 | 0.0137 | 0.0137 |
Onchocerca volvulus | Tyrosine kinase homolog | 0.0004 | 0 | 0.5 |
Loa Loa (eye worm) | CAMK/CAMKL/CHK1 protein kinase | 0.0165 | 0.2119 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.0099 | 0.0466 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.0099 | 0.0466 |
Schistosoma mansoni | nephrin | 0.0014 | 0.0137 | 0.0647 |
Echinococcus granulosus | neuroglian | 0.0014 | 0.0137 | 0.0137 |
Echinococcus multilocularis | thymidine phosphorylase | 0.0765 | 1 | 1 |
Echinococcus granulosus | neurotracting:lsamp:neurotrimin:obcam | 0.0011 | 0.0099 | 0.0099 |
Mycobacterium ulcerans | thymidine phosphorylase | 0.0765 | 1 | 1 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0013 | 0.0112 | 0.0068 |
Mycobacterium leprae | Probable anthranilate phosphoribosyltransferase TrpD | 0.0216 | 0.2785 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0014 | 0.0137 | 0.0647 |
Loa Loa (eye worm) | TK protein kinase | 0.0101 | 0.1279 | 0.6037 |
Schistosoma mansoni | Neurotrimin precursor (hNT) | 0.0011 | 0.0099 | 0.0466 |
Echinococcus granulosus | basic fibroblast growth factor receptor 1 A | 0.0098 | 0.1241 | 0.1241 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0101 | 0.1279 | 0.5843 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.0099 | 0.0466 |
Echinococcus multilocularis | neuroglian | 0.0014 | 0.0137 | 0.0137 |
Echinococcus granulosus | Immunoglobulin | 0.0011 | 0.0099 | 0.0099 |
Echinococcus multilocularis | Immunoglobulin | 0.0011 | 0.0099 | 0.0099 |
Echinococcus multilocularis | Immunoglobulin | 0.0011 | 0.0099 | 0.0099 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.0099 | 0.0466 |
Echinococcus multilocularis | basic fibroblast growth factor receptor 1 A | 0.0098 | 0.1241 | 0.1241 |
Echinococcus granulosus | fibroblast growth factor receptor 4 | 0.0098 | 0.1241 | 0.1241 |
Mycobacterium tuberculosis | Probable thymidine phosphorylase DeoA (tdrpase) (pyrimidine phosphorylase) | 0.0765 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 43.32 uM | Inhibition of human recombinant thymidine phosphorylase expressed in Escherichia coli using thymidine as substrate after 4 to 20 mins by spectrophotometry | ChEMBL. | 23871912 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.